Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Top 10 Copper-producing Companies (Updated 2024)

Could the Silver Price Really Hit US$100 per Ounce? (Updated 2024)

Where Does Tesla Get its Lithium? (Updated 2024)

Rare Earths Reserves: Top 8 Countries (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies

Top 10 Countries for Natural Gas Production (Updated 2024)

Top 5 Junior Gold Stocks on the TSXV in 2024

A State-by-State Guide to Cannabis in Australia

7 Biggest Lithium-mining Companies

Trending Press Releases

Indicative, Conditional and Non-Binding Proposal Received by American Rare Earths

Freegold Announces Start of 2024 Drilling Program at Golden Summit

Beyond Lithium and Its Exploration Team Recognized with Bernie Schnieders Discovery of the Year Award

Elixir Energy Limited (ASX: EXR) – Trading Halt

Purepoint Uranium Group Inc. Launches Strategic Drill Program at Turnor Lake Project Targeting the La Rocque Structural Corridor

Falco Resources: Canadian Explorer in the Rouyn-Noranda Mining Camp

More Press Releases
Trending Companies

Jindalee Lithium

JLL:AU

Elixir Energy

EXR:AU

Forward Water Technologies

FWTC:CA

Rio Silver

RYO:CA
More Companies
Trending Reports

2024 Gold Outlook Report

2024 Uranium Outlook (Updated for Q2)

Lithium Outlook for Australia

2024 Lithium Market Outlook

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold
Copper
Uranium
Oil and Gas
Artificial Intelligence
Biotech
loader

Summit Therapeutics Inc.

NASDAQ:SMMT
Press Releases

Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection

Summit Therapeutics Announces PhaseOut DMD Did Not Meet Primary Endpoint

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its lead CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

×